| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,770 | $30 | $149.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,360 | $100 | $134.9K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 4,270 | $30 | $132.4K |
| J0897 | Injection, denosumab, 1 mg | 4,260 | $20 | $76.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 7,600 | $10 | $76K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $110 | $38.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 120 | $130 | $16K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 250 | $60 | $15.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 160 | $70 | $11.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 250 | $20 | $5.8K |